7 Eight Capital LP purchased 26,831 shares of Ultragenyx Pharmaceutical Inc., increasing their holdings to 45,906 shares.

7 Eight Capital LP purchased 26,831 shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) in the fourth quarter, increasing their holdings to 45,906 shares with a market value of $2.2 million. Other investors and hedge funds such as Sands Capital Management LLC and Norges Bank also bought shares in the company during this period.